Post-exercise nasal vasoconstriction and hyporeactivity: Possible involvement of neuropeptide Y

Acta Oto-Laryngologica

Volumn 117, Issue 4, 1997, Pages 609-613

  Lacroix, J S ^a,c   Correia, F ^a   Fathi, M ^a   Grouzmann, E ^b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c University Hospital   (Switzerland)

Author keywords

Capsaicin; Nasal mucosa; Neuropeptide Y; Parasympathetic; Physical exercise; Sympathetic

Indexed keywords

CAPSAICIN; NEUROPEPTIDE Y;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CATECHOLAMINE BLOOD LEVEL; ELECTROSTIMULATION; EXERCISE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NOSE AIRWAY RESISTANCE; PARASYMPATHETIC INNERVATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RHINORRHEA; VASOCONSTRICTION;

EID: 0030849292     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709113446     Document Type: Article

References (25)

1. Proetz. AW. Essays on applied physiology of the nose, 2nd edn. St. Louis: Annals Publishing Company, 1953; 330.
2. Richerson HB, Seebohm PM. Nasal airway response to exercise. J Allergy 1968; 41: 269-84.
3. Dallimore NS, Eccles R. Changes in human nasal resistance associated with exercise, hyperventilation and rebreathing. Acta Otolaryngol (Stockh) 1977; 84: 416-21.
4. Forsyth RD, Cole P, Shepphard RJ. Exercise and nasal patency. J Appl Physiol 1983; 55: 860-5.
5. Konno A, Tereda N, Okamoto Y, Togawa K. The effect of cold exposure and exercise upon the nasal mucosal responses in nasal allergy. Ann Allergy 1985; 54: 50-9.
6. Konno A, Togawa K, Isaka A. Neurophysiological mechanisms of shrinkage of nasal mucosa induced by exercise. Auris Nasus Larynx (Tokyo) 1982; 9: 81-90.
7. Änggård A, Denser O. Adrenergic innervation of the nasalmucosa in cat. A histological and physiological study. Acta Otolaryngol (Stockh) 1974; 78: 232-41.
8. Lundberg JM, Terenius L, Hökfelt T, Martling CR, Tatemoto K, Muttm V, Polak J, Bloom S, Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects on NPY on sympathetic function. Acta Physiol Scand 1982; 116: 477-80.
9. Lacroix JS. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand 1989; 136 Suppl. 581: 1-63.
10. Lacroix JS, Änggård A, Hökfelt T, et al. Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa. Cell Tissue Res 1990; 259: 119-28.
11. Pernow J, Lundberg JM, Kaijser L, et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 1986; 6: 561-78.
12. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ. Neuropeptide Y is a vasoconstrictor in human nasal mucosa. J Appl Physiol 1992; 73: 1867-72.
13. Lundberg JM, Franco-Cereceda A, Hemsen A, Lacroix JS, Pernow J. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission. Fundam Clin Pharmacol 1990; 4: 373-91.
14. Stretton CD, Barnes PJ. Modulation of cholinergic neurotransmission in guinea-pig trachea by NPY. Br J Pharmacol 1988; 93: 672-8.
15. Potter EK. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neurosci Lett 1985; 54: 117-21.
16. 2-adrenoceptors and opiate receptors. Eur J Pharmacol 1989; 163: 15-23.
17. Lacroix JS, Ricchetti AP, Morel D, Mossimann B, Waeber B, Grouzmann E. Intranasal administration of NPY in man: systemic absorbtion and functional effects. Br J Pharmacol 1996; 118: 2079-84.
18. Secher C, Kirkegsaardl J, Borum P, Mansson A, Osterhammel P, Mygind N. Significance of H2 and H1 receptors in the human nose: rational for topical use of combined antihistamine preparations. J Allergy Clin Immun 1982; 70: 211-8.
19. Grouzmann E, Aubert JF, Waeber B, Brunner HR. A sensitive and specific two-site, sandwich amplified enzyme immunoassay for NPY. Peptides 1992; 13: 1249-54.
20. Favre L, Forster A, Fathi M, Valloton M. Calcium chanel inhibition in pheochromocytoma. Acta Endocrinol 1986; 113: 385-90.
21. Christensen NJ, Galbo H. Sympathetic nervous activity during exercise. Rev Physiol 1983; 139-53.
22. Stjärne P, Lundblad, L, Lundberg, JM, Änggård A. Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol 1989; 96: 693-701.
23. Lacroix JS, Lundberg JM. Neural reflex pathways in rhinitis. In: Busse W, and Holgate ST eds. Asthma and rhinitis. London: Blackwell, 1984; 52: 686-90.
24. Nuki C, Kawasaki H, Takasaki K. Effect of neuropeptide Y on vasodilatation mediated by calcitonine gene-related peptide (CGRP)-containing nerves in the mesenteric resistance vessels of the rat. Jpn J Pharmacol 1990; 53: 125-8.
25. 2 prejunctional receptor. Br J Pharmacol 1994; 113: 479-84.